Brian Lenz - Feb 25, 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
EVP, CFO
Signature
/s/ Brian Lenz
Stock symbol
ADMA
Transactions as of
Feb 25, 2023
Transactions value $
-$107,873
Form type
4
Date filed
3/8/2023, 08:30 PM
Previous filing
Jan 6, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Tax liability -$5.33K -1.56K -0.17% $3.42 919K Feb 25, 2023 Direct
transaction ADMA Common Stock Tax liability -$27.1K -7.93K -0.86% $3.42 911K Feb 25, 2023 Direct
transaction ADMA Common Stock Tax liability -$17.8K -5K -0.55% $3.55 906K Feb 28, 2023 Direct
transaction ADMA Common Stock Award $0 +135K +14.92% $0.00 1.04M Mar 6, 2023 Direct
transaction ADMA Common Stock Tax liability -$57.7K -17K -1.63% $3.40 1.02M Mar 7, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Employee Stock Option (right to buy) Award $0 +270K $0.00 270K Mar 6, 2023 Common Stock 270K $3.35 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 135,175 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 103,125 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 247,500 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which shall vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
F2 (continued from footnote 1) (iv) 30,480 unvested RSUs granted on February 25, 2021, of which 27,500 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 2,980 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;
F3 (continued from footnote 2) (v) 10,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 498,047 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F4 The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 6, 2027.